Implementation of a surgical site infection prevention bundle in gynecologic oncology patients: An enhanced recovery after surgery initiative.

OBJECTIVE: To evaluate the clinical outcomes pre- and post-implementation of an evidence-informed surgical site infection prevention bundle (SSIPB) in gynecologic oncology patients within an Enhanced Recovery After Surgery (ERAS) care pathway. METHODS: Patients undergoing laparotomy for a gynecologic oncology surgery between January-June 2017 (pre-SSIPB) and between January 2018-December 2020 (post-SSIPB) were compared using t-tests and chi-square. Patient characteristics, surgical factors, and ERAS process measures and outcomes were abstracted from the ERAS® Interactive Audit System (EIAS). The primary outcomes were incidence of surgical site infections (SSI) during post-operative hospital admission and at 30-days post-surgery. Secondary outcomes included total postoperative infections, length of stay, and any surgical complications. Multivariate models were used to adjust for potential confounding factors. RESULTS: Patient and surgical characteristics were similar in the pre- and post-implementation periods. Evaluation of implementation suggested that preoperative and intraoperative components of the intervention were most consistently used. Infectious complications within 30 days of surgery decreased from 42.1% to 24.4% after implementation of the SSIPB (p < 0.001), including reductions in wound infections (17.0% to 10.8%, p = 0.02), urinary tract infections (UTI) (12.7% to 4.5%, p < 0.001), and intra-abdominal abscesses (5.4% to 2.5%, p = 0.05). These reductions were associated with a decrease in median length of stay from 3 to 2 days (p = 0.001). In multivariate analysis, these SSI reductions remained statistically significant after adjustment for potential confounders. CONCLUSION: Implementation of SSIPB was associated with a reduction in SSIs and infectious complications, as well as a shorter length of stay in gynecologic oncology patients.

Sustainability of an enhanced recovery pathway after minimally invasive gynecologic oncology surgery.

OBJECTIVE: Same day discharge is safe after minimally invasive gynecology oncology surgery. Our quality improvement peri-operative program based on enhanced recovery after surgery principles led to an increase in same day discharge from 30% to 75% over a 12 month period. Twelve months after program implementation, we assessed the sustainability of same day discharge rates, determined post-operative complication rates, and evaluated factors affecting same day discharge rates. METHODS: A retrospective chart review was conducted of 100 consecutive patients who underwent minimally invasive surgery at an academic cancer center from January to 2021 to December 2021. This cohort was compared with the active intervention cohort (n=102) from the implementation period (January 2020 to December 2020). Same day discharge rates and complications were compared. Multivariable analysis was performed to assess which factors remained associated with same day discharge post-intervention. RESULTS: Same day discharge post-intervention was 72% compared with 75% during active intervention (p=0.69). Both cohorts were similar in age (p=0.24) and body mass index (p=0.27), but the post-intervention cohort had longer operative times (p=0.001). There were no significant differences in 30-day complications, readmission, reoperation, or emergency room visits (p>0.05). There was a decrease in 30-day post-operative clinic visits from 18% to 5% in the post-intervention cohort (p=0.007), and unnecessary bowel prep use decreased from 35% to 14% (p<0.001). On multivariable analysis, start time (second case of the day) (OR 0.06; 95% CI 0.01 to 0.35), and ward narcotic use (OR 0.12; 95% CI 0.03 to 0.42) remained associated with overnight admission. CONCLUSION: Same day discharge rate was sustained at 72%, 12 months after the implementation of a quality improvement program to optimize same day discharge rate after minimally invasive surgery, while maintaining low post-operative complications and reducing unplanned clinic visits. To maximize same day discharge, minimally invasive gynecologic oncology surgery should be prioritized as the first case of the day, and post-operative narcotic use should be limited.

Enhanced recovery after surgery (ERAS) for deep infiltrating endometriosis surgery: Experience of a French center.

OBJECTIVE: The objective of the study was to evaluate the implementation of an ERAS programme for deep pelvic endometriosis (DPE) surgery in terms of length of stay (LOS), postoperative complications (POC) and rehospitalisation rate. METHODS: This was a comparative retrospective monocentric study in the Gynaecologic Department of the La Conception Hospital in Marseille, France. We compared a 'conventional' group, with classic perioperative management corresponding to patients undergoing DPE surgery between April 8, 2014 and January 23, 2018, and an 'ERAS' group after setting up the ERAS protocol from February 6, 2018 to March 6, 2020. RESULTS: A total of 101 patients with DPE surgery were included, with 39 in the conventional group and 53 in the ERAS group. The LOS decreased by 1.91 days (p < 0.001). During the 45 postoperative days, no difference was found in rehospitalised rate (p = 1). The POC rate was 15/39 (38.5 %) in the conventional group and 12/53 (22.6 %) in the ERAS group (p = 0.1). CONCLUSION: The implementation of an ERAS programme for DPE surgery is an effective strategy because it can reduce the LOS without increasing the POC rate.

Cirurgia ginecológica e COVID-19: qual o impacto e como devo conduzir? / Gynecological Surgery and COVID-19: What is the Impact and How Should I Manage it?

Estima-se que cerca de 28 milhões de cirurgias sejam postergadas ou canceladas no mundo em decorrência desta pandemia, causando atraso no diagnóstico e tratamento de mais de 2 milhões de casos oncológicos. No Brasil, tanto a ANS (Agência Nacional de Saúde) como a Anvisa (Agência Nacional de Vigilância Sanitária) orientaram o adiamento das cirurgias eletivas e não essenciais, tendo um impacto considerável no número de procedimentos cirúrgicos, com diminuição de 33,4% neste período no Brasil. No entanto, algumas mulheres necessitam de tratamento para várias doenças ginecológicas, algumas das quais não podem ser adiadas. O objetivo deste artigo é apresentar recomendações sobre o tratamento cirúrgico durante a pandemia de COVID-19.(AU)

Guidelines for perioperative care in gynecologic/oncology: Enhanced Recovery After Surgery (ERAS) Society recommendations - 2019 update

Enhanced Recovery After Surgery (ERAS) is now firmly established as a global surgical quality improvement initiative that results in both clinical improvements1 and cost benefits to the healthcare system.2 ERAS guidelines are based on the highest quality evidence available and as such require updating on a regular basis.3 The ERAS Gynecologic/Oncology guidelines4 5 were first published in February 2016. This article represents the joint efforts of the ERAS® Society (www.erassociety.org) and authors from the international ERAS Gynecology chapters to present an updated consensus review of perioperative care for gynecologic/oncology surgery based on best current evidence.

Effect of preheating on the maintenance of body temperature in surgical patients: a randomized clinical trial / Efeito do pré-aquecimento na manutenção da temperatura corporal do paciente cirúrgico: ensaio clínico randomizado / Efecto del pre-calentamiento en el mantenimiento de la temperatura corporal del paciente quirúrgico: ensayo clínico aleatorizado

ABSTRACT Objective: to evaluate the effect of preheating on the maintenance of body temperature of patients submitted to elective gynecological surgeries. Method: eighty-six patients were randomized, without blinding, to receive usual care (heating with a cotton sheet and blanket) or preheating with a forced air system for 20 minutes (38°C). All patients were actively heated during the intraoperative period. Data were collected from admission of the patient in the surgical center until the end of the surgery. Body temperature was measured during the preoperative and intraoperative periods with an infrared tympanic thermometer. A thermo-hygrometer was used to monitor air temperature and humidity of the operating room. Results: data indicated homogeneity between the groups investigated. There was no statistically significant difference between groups after preheating (p = 0.27). At the end of the surgery, the mean temperature of the groups studied was the same (36.8°C), with a statistically non-significant difference (p = 0.66). Conclusion: preheating with the heated forced air system had a similar effect to the usual care in the body temperature of patients submitted to elective gynecological surgeries. ClinicalTrials.gov n. NCT02422758. CAAE, n. 38320814.2.0000.5393.

RESUMO Objetivo: avaliar o efeito do pré-aquecimento na manutenção da temperatura corporal de pacientes submetidas a cirurgias ginecológicas eletivas. Método: foram randomizadas 86 pacientes, sem cegamento, para receber cuidado usual (aquecimento com lençol de algodão e cobertor) ou pré-aquecimento com o uso do sistema de ar forçado aquecido, durante 20 minutos (38°C). Todas as pacientes foram aquecidas de forma ativa durante o período intraoperatório. Os dados foram coletados da admissão da paciente no centro cirúrgico até o final da cirurgia. A temperatura corporal foi mensurada durante os períodos pré e intraoperatório com termômetro timpânico infravermelho. Para a temperatura e umidade do ar da sala cirúrgica, utilizou-se o termo-higrômetro. Resultados: os dados indicaram homogeneidade entre os grupos investigados. Não houve diferença estatisticamente significante entre os grupos após o pré-aquecimento (p=0,27). Ao final da cirurgia, a temperatura média dos grupos estudados foi igual (36,8°C), com diferença estatisticamente não significante (p=0,66). Conclusão: o pré-aquecimento com o sistema de ar forçado aquecido teve efeito semelhante ao cuidado usual na temperatura corporal de pacientes submetidas a cirurgias ginecológicas eletivas. ClinicalTrials.gov n. NCT02422758. CAAE, n. 38320814.2.0000.5393.

RESUMEN Objetivo: evaluar el efecto del pre-calentamiento en el mantenimiento de la temperatura corporal de pacientes sometidas a cirugías ginecológicas electivas. Método: 86 pacientes fueron aleatorizados, sin ceguera, para recibir cuidado usual (calentamiento con sábanas de algodón y manta) o pre-calentamiento con el uso del sistema de aire forzado calentado, durante 20 minutos (38°C). Todas las pacientes fueron calentadas de forma activa durante el período intra-operatorio. Los datos fueron recogidos de la admisión de la paciente en el centro quirúrgico hasta el final de la cirugía. La temperatura corporal fue medida durante los períodos pre e intra-operatorio con un termómetro timpánico infrarrojo. Para la temperatura y humedad del aire de la sala quirúrgica, se utilizó el termo-higrómetro. Resultados: los datos indicaron homogeneidad entre los grupos investigados. No hubo diferencia estadísticamente significante entre los grupos después del pre-calentamiento (p=0,27). Al final de la cirugía, la temperatura media de los grupos estudiados fue igual (36,8°C), con diferencia estadísticamente no significante (p=0,66). Conclusión: el pre-calentamiento con el sistema de aire forzado calentado tuvo efecto semejante al cuidado usual en la temperatura corporal de pacientes sometidas a cirugías ginecológicas electivas. ClinicalTrials.gov n. NCT02422758. CAAE, n. 38320814.2.0000.5393.

Manual de normas y procedimientos para el control del cáncer ginecológico / Standards and procedures manual for the control of ginecological cancer

Su objetivo es promover y desarrollar las acciones técnico administrativas para el control del cáncer ginecológico en la población, principalmente de cérvix y mama, en especial de aquellas mujeres con factores de riesgo, poniendo énfasis en la detección precoz y unificando criterios de tratamiento a través de actividades de intervención en la institución y la comunidad